These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1739084

  • 21. Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial.
    Hofstra JM, Branten AJ, Wirtz JJ, Noordzij TC, du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2010 Jan; 25(1):129-36. PubMed ID: 19666912
    [Abstract] [Full Text] [Related]

  • 22. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N, Robeva R, Dimitrova V.
    Vutr Boles; 1990 Jan; 29(3):53-60. PubMed ID: 2284800
    [Abstract] [Full Text] [Related]

  • 23. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
    Polenakovic M, Grcevska L, Dzikova S.
    Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
    [Abstract] [Full Text] [Related]

  • 24. The natural history of the non-nephrotic membranous nephropathy patient.
    Hladunewich MA, Troyanov S, Calafati J, Cattran DC, Metropolitan Toronto Glomerulonephritis Registry.
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1417-22. PubMed ID: 19661220
    [Abstract] [Full Text] [Related]

  • 25. Clinical Predictors of Response to Prednisone Plus Cyclophosphamide in Patients with Idiopathic Membranous Nephropathy.
    Li S, Wang L, Zhang M, Zhou W, Fang W, Wang Q, Qi C, Mou S, Shao X, Ni Z.
    Nephron; 2017 Sep; 135(2):87-96. PubMed ID: 27974710
    [Abstract] [Full Text] [Related]

  • 26. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression.
    Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S, Lai KN.
    Lupus; 1999 Sep; 8(7):545-51. PubMed ID: 10483033
    [Abstract] [Full Text] [Related]

  • 27. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
    Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.
    Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
    [Abstract] [Full Text] [Related]

  • 28. Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.
    Yang S, Xie L, Xue W, Yin A, Lu W.
    Nephrology (Carlton); 2013 Sep; 18(9):615-22. PubMed ID: 23889815
    [Abstract] [Full Text] [Related]

  • 29. Effect of prolonged tacrolimus treatment in idiopathic membranous nephropathy with nephrotic syndrome.
    Yuan H, Liu N, Sun GD, Jia Y, Luo P, Miao LN.
    Pharmacology; 2013 Sep; 91(5-6):259-66. PubMed ID: 23652322
    [Abstract] [Full Text] [Related]

  • 30. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 31. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V.
    J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
    [Abstract] [Full Text] [Related]

  • 32. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.
    Torres A, Domínguez-Gil B, Carreño A, Hernández E, Morales E, Segura J, González E, Praga M.
    Kidney Int; 2002 Jan; 61(1):219-27. PubMed ID: 11786104
    [Abstract] [Full Text] [Related]

  • 33. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [Abstract] [Full Text] [Related]

  • 34. [Membranous nephropathy and crescentic glomerulonephritis].
    Vozmediano C, Sánchez de la Nieta MD, González L, Alvarez T, de la Torre M, Blanco J, Nieto J, Rivera F.
    Nefrologia; 2005 Nov; 25(3):328-31. PubMed ID: 16053015
    [Abstract] [Full Text] [Related]

  • 35. Membranous glomerulonephritis: treatment response and outcome in children.
    Valentini RP, Mattoo TK, Kapur G, Imam A.
    Pediatr Nephrol; 2009 Feb; 24(2):301-8. PubMed ID: 18846392
    [Abstract] [Full Text] [Related]

  • 36. Immunosuppressive therapy with cyclophosphamide and prednisolone in severe idiopathic membranous nephropathy.
    Kibriya MG, Tishkov I, Nikolov D.
    Nephrol Dial Transplant; 1994 Feb; 9(2):138-43. PubMed ID: 8190328
    [Abstract] [Full Text] [Related]

  • 37. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [Abstract] [Full Text] [Related]

  • 38. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan.
    Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, Yokoyama H, Nishi S, Tomino Y, Kurokawa K, Sakai H, Research Group on Progressive Renal Diseases in Japan.
    Kidney Int; 2004 Apr; 65(4):1400-7. PubMed ID: 15086481
    [Abstract] [Full Text] [Related]

  • 39. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF, Farine M, Thorner P, Baumal R.
    Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
    [Abstract] [Full Text] [Related]

  • 40. The therapy of idiopathic membranous glomerulonephritis.
    Glassock RJ.
    Semin Nephrol; 1991 Mar; 11(2):138-47. PubMed ID: 2034923
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.